PharmaMar

PharmaMar is a global biopharmaceutical company based in Madrid, Spain. It is dedicated to the discovery, development, and commercialization of innovative therapies based on marine-derived compounds for the treatment of serious diseases, particularly cancer.

History[edit | edit source]

PharmaMar was founded in 1986 with the aim of developing new medications from marine organisms. The company's research and development efforts have resulted in several marketed products and a robust pipeline of drug candidates.

Products[edit | edit source]

PharmaMar's product portfolio includes Yondelis, a drug used for the treatment of soft tissue sarcoma and ovarian cancer, and Zepsyre, a drug candidate in clinical development for several solid tumors.

Research and Development[edit | edit source]

PharmaMar's Research and Development department is focused on the discovery of new marine-derived compounds and the development of innovative therapies for the treatment of cancer. The company's R&D efforts are supported by a state-of-the-art research facility in Madrid.

Partnerships[edit | edit source]

PharmaMar has established numerous partnerships with leading pharmaceutical and biotechnology companies worldwide to further the development and commercialization of its products.

References[edit | edit source]

External Links[edit | edit source]

Official website

This pharmacology-related article is a stub. You can help WikiMD by expanding it.

Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Search WikiMD

Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro) available.
Advertise on WikiMD

WikiMD is not a substitute for professional medical advice. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.